A detailed history of Manufacturers Life Insurance Company, The transactions in Chroma Dex Corp. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 19,732 shares of CDXC stock, worth $108,328. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,732
Previous 11,247 75.44%
Holding current value
$108,328
Previous $30,000 140.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.51 - $3.8 $21,297 - $32,243
8,485 Added 75.44%
19,732 $72,000
Q2 2024

Aug 14, 2024

BUY
$2.44 - $4.32 $27,442 - $48,587
11,247 New
11,247 $30,000
Q2 2022

Aug 15, 2022

SELL
$1.59 - $2.7 $17,933 - $30,453
-11,279 Closed
0 $0
Q1 2022

Aug 11, 2023

BUY
$2.02 - $3.92 $22,783 - $44,213
11,279 New
11,279 $27,000
Q1 2022

May 20, 2022

SELL
$2.02 - $3.92 $30,497 - $59,184
-15,098 Reduced 57.24%
11,279 $28,000
Q4 2021

Feb 16, 2022

BUY
$3.74 - $6.7 $534 - $958
143 Added 0.55%
26,377 $99,000
Q3 2021

Nov 12, 2021

SELL
$6.05 - $10.41 $5,499 - $9,462
-909 Reduced 3.35%
26,234 $164,000
Q2 2021

Aug 12, 2021

BUY
$6.66 - $10.92 $23,836 - $39,082
3,579 Added 15.19%
27,143 $268,000
Q1 2021

May 03, 2021

SELL
$4.59 - $18.74 $17,483 - $71,380
-3,809 Reduced 13.92%
23,564 $220,000
Q4 2020

Feb 12, 2021

BUY
$3.93 - $5.5 $5,454 - $7,634
1,388 Added 5.34%
27,373 $131,000
Q2 2020

Aug 10, 2020

SELL
$3.0 - $5.52 $6,051 - $11,133
-2,017 Reduced 7.2%
25,985 $118,000
Q1 2020

May 15, 2020

BUY
$2.54 - $4.75 $4,579 - $8,564
1,803 Added 6.88%
28,002 $91,000
Q4 2019

Feb 14, 2020

SELL
$2.83 - $4.61 $2,261 - $3,683
-799 Reduced 2.96%
26,199 $113,000
Q2 2019

Aug 14, 2019

SELL
$3.71 - $4.83 $7,279 - $9,476
-1,962 Reduced 6.77%
26,998 $126,000
Q1 2019

May 13, 2019

BUY
$3.2 - $4.19 $92,672 - $121,342
28,960 New
28,960 $121,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $375M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.